Track MyMD Pharmaceuticals, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

MyMD Pharmaceuticals, Inc. MYMD · Stock Open MyMD Pharmaceuticals, Inc. in new tab

1.81 USD
Loading chart...

DCF valuation

Model fair value for MyMD Pharmaceuticals, Inc. (MYMD)
Result
Sign in to run the valuation for MYMD.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

MyMD Pharmaceuticals, Inc. Logo MyMD Pharmaceuticals, Inc. Analysis (MYMD)

United States Health Care Official Website Stock

Is MyMD Pharmaceuticals, Inc. a good investment? MyMD Pharmaceuticals, Inc. (MYMD) is currently trading at 1.81 USD.

Investor FAQ

Does MyMD Pharmaceuticals, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is MyMD Pharmaceuticals, Inc.?

MyMD Pharmaceuticals, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Exchange Ticker
NMS (United States) MYMD
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Nov. 8, 2018 0.12
Nov. 25, 2019 1:25
April 19, 2021 1:2
Feb. 15, 2024 0.03
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion